Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-02-23 @ 11:34 AM
Study NCT ID:
NCT01659658
Status:
TERMINATED
Last Update Posted:
2025-09-02
First Post:
2012-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-02
First Submit QC Date:
None
Study First Post Date:
2012-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-07-10
Results First Submit QC Date:
None
Results First Post Date:
2023-09-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-28
Last Update Post Date:
2025-09-02
Last Update Post Date Type:
ESTIMATED